Abstract:Abstract Objectives Vitamin K (VK) is a family of structurally-related quinones, phylloquinone (PK) and menaquinones (MKn, n = prenyl units in side chain), that share a common napthoquinone ring (menadione, MD). VK quinones function as an essential dietary nutrient for humans. MD is considered a pro-vitamin form of VK. Plants and bacteria that produce VK quinones (PK and MKn, respectively) use them as an electron carrier in energy production. Little is known about the interaction of dietary VK quinones with gut bacteria, which may be bi-directional. The objective of this study was to investigate the influence of VK quinones and MD on human gut bacteria composition and MKn production. Methods Stool from 5 healthy male donors was pooled and inoculated in bioreactors under conditions mimicking the colon (anaerobic, pH 6.8, 37°C) for 48 h. Bioreactors were treated with deuterium (2H)-labeled quinones (2H-PK, 2H-MK4, 2H-MK9 or 2H-MD); no quinones (cell controls); or 2H-quinone treatment with no stool (cell-free controls). Culture aliquots were collected at 0, 5, 10, 24, and 48 h, and separated into pellet and supernatant fractions. Experiments were conducted in triplicate. All fractions were analyzed for VK quinone content using LC-MS. DNA from 0 and 24 h pellet fractions was extracted and amplified for paired-end 16S sequencing on an Illumina MiSeq 2500. Differences in bacterial composition were assessed using PERMANOVA. Results Supplemented 2H-quinones accumulated in the pellet fraction over time. This was not observed in cell-free controls and was thus not a function of culture media solubility. Endogenous (unlabeled) production of MKn was unaffected by supplementation of 2H-quinones. Generated 2H-MKn (2H-MK4, 2H-MK9, 2H-MK10, and 2H-MK11) were only detected in 2H-MD supplemented vessels. Community-wide bacterial composition significantly differed between 0 h and 24 h (r2 = 0.85, P = 0.001), but not by quinone treatment. Conclusions PK and MKn, dietary viamin K quinones, were not transformed by gut microbes to MKn in vitro, whereas the pro-vitamin quinone MD was transformed to MKn of multiple side chain lengths. Although no quinone induced community-wide changes in bacteria composition, additional analyses are needed to assess species-specific growth promotion. Funding Sources USDA ARS and DOD Health Program.

Microbial Production of Vitamin K2: Current Status and Future Prospects.

The efficient green bio-manufacturing of Vitamin K2: design, production and applications

Production of Vitamin K by Wild-Type and Engineered Microorganisms

Vitamin K series: current status and future prospects

Production and application of menaquinone-7 (vitamin K2): a new perspective

Increasing Vitamin K2 Synthesis in Bacillus subtilis by Controlling the Expression of MenD and Stabilizing MenA

Enhanced vitamin K2 production by engineered Bacillus subtilis during leakage fermentation

Vitamin K2: known and unknown. Modern view: opportunities and prospects

Engineering microbial consortia of Elizabethkingia meningoseptica and Escherichia coli strains for the biosynthesis of vitamin K2

The biological responses of vitamin K2: A comprehensive review

Vitamin K2 in Health and Disease: A Clinical Perspective

Advances in Enhanced Menaquinone-7 Production from Bacillus Subtilis

Vitamin K metabolism and nutriture

Key Pathways and Regulators of Vitamin K Function and Intermediary Metabolism.

A Perspective of Diverse Synthetic Approaches and Biological Applications of Vitamin K

Vitamin K : A Micro-Nutrient with New Perspective

Molecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities

Engineering Lactococcus lactis for Increased Vitamin K2 Production

Investigation of Vitamin K Quinone Metabolism by Human Gut Bacteria

Enhancing menaquinone-7 biosynthesis through strengthening precursor supply and product secretion

Dietary vitamin K is remodeled by gut microbiota and influences community composition